These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16421722)

  • 61. HLA-G expression in human melanoma cells: protection from NK cytolysis.
    Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
    J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exosomes bearing HLA-G are released by melanoma cells.
    Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
    Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
    Gottlieb DJ; Li YC; Lionello I; Tanzarella S; Marangolo M; Bradstock KF; Russo V; Traversari C
    Br J Cancer; 2006 Jul; 95(2):181-8. PubMed ID: 16819544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.
    Labarriere N; Diez E; Pandolfino MC; Viret C; Guilloux Y; Le Guiner S; Fonteneau JF; Dreno B; Jotereau F
    J Immunol; 1997 Feb; 158(3):1238-45. PubMed ID: 9013965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics.
    Sanchez-Mazas A; Nunes JM; Middleton D; Sauter J; Buhler S; McCabe A; Hofmann J; Baier DM; Schmidt AH; Nicoloso G; Andreani M; Grubic Z; Tiercy JM; Fleischhauer K
    HLA; 2017 Feb; 89(2):104-113. PubMed ID: 28102034
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
    Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
    Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines.
    Pollack MS; Heagney SD; Livingston PO; Fogh J
    J Natl Cancer Inst; 1981 Jun; 66(6):1003-12. PubMed ID: 7017212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune escape mechanisms in malignant melanoma.
    Geertsen R; Hofbauer G; Kamarashev J; Yue FY; Dummer R
    Int J Mol Med; 1999 Jan; 3(1):49-57. PubMed ID: 9864385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
    Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
    Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro differentiation and antigenic changes in human melanoma cell lines.
    Guarini L; Temponi M; Edwalds GM; Vita JR; Fisher PB; Ferrone S
    Cancer Immunol Immunother; 1989; 30(5):262-8. PubMed ID: 2624919
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview.
    Riegman PH; Dinjens WN; Oomen MH; Spatz A; Ratcliffe C; Knox K; Mager R; Kerr D; Pezzella F; van Damme B; van de Vijver M; van Boven H; Morente MM; Alonso S; Kerjaschki D; Pammer J; Lopez-Guerrero JA; Llombart Bosch A; Carbone A; Gloghini A; Teodorovic I; Isabelle M; Jaminé D; Passioukov A; Lejeune S; Therasse P; van Veen EB; Lam KH; Oosterhuis JW
    Eur J Cancer; 2006 Nov; 42(16):2678-83. PubMed ID: 17027254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues.
    Andalib AR; Lawry J; Ali SA; Murray AK; Sisley K; Silcocks P; Herlyn M; Rees RC
    Melanoma Res; 1997 Feb; 7(1):32-42. PubMed ID: 9067963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines.
    Pollack MS; Livingston PO; Fogh J; Carey TE; Oettgen HF; Dupont B
    Tissue Antigens; 1980 Mar; 15(3):249-56. PubMed ID: 6451045
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents.
    Guarini L; Graham GM; Jiang H; Ferrone S; Zucker S; Fisher PB
    Pigment Cell Res; 1992; Suppl 2():123-31. PubMed ID: 1357650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
    J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phenotypic heterogeneity of HLA products on human melanoma cells.
    Parmiani G; Taramelli D; Anichini A; Andreola S; Cascinelli N; Fossati G
    J Immunogenet; 1986; 13(2-3):235-40. PubMed ID: 3469277
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
    Versteeg R; Krüse-Wolters KM; Plomp AC; van Leeuwen A; Stam NJ; Ploegh HL; Ruiter DJ; Schrier PI
    J Exp Med; 1989 Sep; 170(3):621-35. PubMed ID: 2788705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.